Skip to content

Efficacy of chicory plant syrup on liver enzymes in patients with acute lymphoblastic leukemia

Evaluation of the effect of oral chicory extract on liver enzymes in patients with acute lymphoblastic leukemia: A clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220526055001N1
Enrollment
110
Registered
2022-11-16
Start date
2022-09-14
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lymphoblastic leukemia. Acute lymphoblastic leukemia [ALL]

Interventions

Intervention 1: The intervention group will receive 5 cc chicory plant extract (Produced by Razi University Pharmaceutical Department)in the form of syrup as a daily supplement for one week to one and

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 17 Years

Inclusion criteria

Inclusion criteria: Children with acute lymphoblastic leukemia (ALL) who have blood levels of liver enzymes more than 4-2 times normal are included in the study In the consent form, giving the participants the right to choose to participate or not to participate in the research and to keep the information confidential A written consent form from the child or their parents is the moral obligation of the researcher not to impose costs on the patients

Exclusion criteria

Exclusion criteria: In case of hepatitis and liver failure, they will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Level of ALT liver enzymes. Timepoint: The beginning of the study, one and a half months, three and six months after the end of the study. Method of measurement: blood test.;Level of liver enzymes AST. Timepoint: The beginning of the study, one and a half months, three and six months after the end of the study. Method of measurement: blood test.;Serum bilirubin level. Timepoint: The beginning of the study, one and a half months, three and six months after the end of the study. Method of measurement: blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Reza Golpaygani

Kermanshah University of Medical Sciences

sara.kooti@kums.ac.ir+98 918 830 2455

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026